Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013).

PMID: 30536209
Journal: Clinical & Translational Oncology
Year: 2019
Reference: Clin Transl Oncol. 2019 Jul;21(7):891-899. doi: 10.1007/s12094-018-1994-1. Epub 2018 Dec 10.
Impact factor:
Publication type: Paper in international publication
Authors: Carbo, A; Comas, R; Izquierdo, A; Marcos-Gragera, R; Pinheiro, P S; Pla, H; Roca-Barcelo, A; Solans, M; Vilardell, L; Vinas, G et al.
DOI: 10.1007/s12094-018-1994-1

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

PMID: 31723992
Journal: BLOOD
Year: 2019
Reference: Blood. 2019 Nov 13;134(Supplement_1):6. doi: 10.1182/blood-2019-123742.
Impact factor: 16.562
Publication type: Paper in international publication
Authors: Bartlett, Nancy L, Assouline, Sarit, Yoon, Sung-Soo, Bosch, Francesc, Sehn, Laurie H, Cheah, Chan Y, Shadman, Mazyar, Gregory, Gareth P, Ku, Matthew, Wei, Michael C et al.
DOI: 10.1182/blood-2019-123742

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

PMID: 31723992
Journal: BLOOD
Year: 2019
Reference: Blood. 2019 Nov 13;134(Supplement_1):6. doi: 10.1182/blood-2019-123742.
Impact factor:
Publication type: Paper in international publication
Authors: Assouline, Sarit; Bartlett, Nancy L; Bosch, Francesc; Budde, Lihua E; Cheah, Chan Y; Gregory, Gareth P; Hernandez, Genevive; Ku, Matthew; Kwan, Antonia; Li, Chi-Chung et al.
DOI: 10.1182/blood-2019-123742

Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.

PMID: 30689894
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2019
Reference: J Antimicrob Chemother. 2019 Apr 1;74(4):1101-1107. doi: 10.1093/jac/dky556.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Fernandez, Maximiliano; Baroja, Aida; Crespo, Manuel; Lopez-Cortes, Luis Eduardo; Martinez-Lamas, Lucia; Nodar, Andres; Perez-Rodriguez, Maria Teresa; Rodriguez-Bano, Jesus; Sousa, Adrian; Val, Nuria et al.
DOI: 10.1093/jac/dky556

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

PMID: 31532396
Journal: AIDS REVIEWS
Year: 2019
Reference: AIDS Rev. 2019;21(3):135-142. doi: 10.24875/AIDSRev.19000088.
Impact factor: 2.357
Publication type: Paper in international publication
Authors: Verger, Christian, Guaraldi, Giovanni, Arends, Joop, Buhk, Thomas, Cascio, Mario, Curran, Adrian, Teofilo, Eugenio, Berk, Guido Van Den et al.
DOI: 10.24875/AIDSRev.19000088

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

PMID: 31532396
Journal: AIDS REVIEWS
Year: 2019
Reference: AIDS Rev. 2019;21(3):135-142. doi: 10.24875/AIDSRev.19000088.
Impact factor:
Publication type: Paper in international publication
Authors: Arends, Joop; Berk, Guido Van Den; Buhk, Thomas; Cascio, Mario; Curran, Adrian; Guaraldi, Giovanni; Teofilo, Eugenio; Verger, Christian et al.
DOI: 10.24875/AIDSRev.19000088

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

PMID: 31050911
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Sep 1;37(25):2257-2269. doi: 10.1200/JCO.18.02050. Epub 2019 May 3.
Impact factor: 28.245
Publication type: Paper in international publication
Authors: Gourley, Charlie, Balmana, Judith, Ledermann, Jonathan A, Serra, Violeta, Dent, Rebecca, Loibl, Sibylle, Pujade-Lauraine, Eric, Boulton, Simon J et al.
DOI: 10.1200/JCO.18.02050

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

PMID: 31050911
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2019
Reference: J Clin Oncol. 2019 Sep 1;37(25):2257-2269. doi: 10.1200/JCO.18.02050. Epub 2019 May 3.
Impact factor:
Publication type: Paper in international publication
Authors: Balmana, Judith; Boulton, Simon J; Dent, Rebecca; Gourley, Charlie; Ledermann, Jonathan A; Loibl, Sibylle; Pujade-Lauraine, Eric; Serra, Violeta et al.
DOI: 10.1200/JCO.18.02050

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

PMID: 30155789
Journal: Brain Imaging and Behavior
Year: 2019
Reference: Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.
Impact factor: 3.418
Publication type: Paper in international publication
Authors: Sandbrink, Rupert, Sprenger, Till, Radue, Ernst-Wilhelm, Wuerfel, Jens, Nichols, Thomas E, Pohl, Christoph, Hartung, Hans-Peter, Montalban, Xavier, Freedman, Mark S, Bendfeldt, Kerstin et al.
DOI: 10.1007/s11682-018-9942-9

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

PMID: 30155789
Journal: Brain Imaging and Behavior
Year: 2019
Reference: Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.
Impact factor:
Publication type: Paper in international publication
Authors: Amann, Michael; Barkhof, Frederik; Bendfeldt, Kerstin; Borgwardt, Stefan; Edan, Gilles; Freedman, Mark S; Gaetano, Laura; Hartung, Hans-Peter; Kappos, Ludwig; Kloppel, Stefan et al.
DOI: 10.1007/s11682-018-9942-9

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

PMID: 31877821
Journal: Pharmaceutics
Year: 2019
Reference: Pharmaceutics. 2019 Dec 21;12(1). pii: pharmaceutics12010016. doi: 10.3390/pharmaceutics12010016.
Impact factor: 4.773
Publication type: Paper in international publication
Authors: Rosell, Anna, Zhang, Yajie, Garcia-Gabilondo, Miguel, Roig, Anna et al.
DOI: 10.3390/pharmaceutics12010016

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

PMID: 31877821
Journal: Pharmaceutics
Year: 2019
Reference: Pharmaceutics. 2019 Dec 21;12(1). pii: pharmaceutics12010016. doi: 10.3390/pharmaceutics12010016.
Impact factor:
Publication type: Paper in international publication
Authors: Garcia-Gabilondo, Miguel; Roig, Anna; Rosell, Anna; Zhang, Yajie et al.
DOI: 10.3390/pharmaceutics12010016

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

PMID: 30767681
Journal: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Year: 2019
Reference: Am J Physiol Gastrointest Liver Physiol. 2019 Jun 1;316(6):G701-G719. doi: 10.1152/ajpgi.00186.2018. Epub 2019 Feb 15.
Impact factor: 3.729
Publication type: Paper in international publication
Authors: Rodino-Janeiro, Bruno Kotska, Pardo-Camacho, Cristina, Santos, Javier, Martinez, Cristina et al.
DOI: 10.1152/ajpgi.00186.2018

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

PMID: 30767681
Journal: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Year: 2019
Reference: Am J Physiol Gastrointest Liver Physiol. 2019 Jun 1;316(6):G701-G719. doi: 10.1152/ajpgi.00186.2018. Epub 2019 Feb 15.
Impact factor:
Publication type: Paper in international publication
Authors: Martinez, Cristina; Pardo-Camacho, Cristina; Rodino-Janeiro, Bruno Kotska; Santos, Javier et al.
DOI: 10.1152/ajpgi.00186.2018

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

PMID: 31434719
Journal: JOURNAL OF CLINICAL MICROBIOLOGY
Year: 2019
Reference: J Clin Microbiol. 2019 Oct 23;57(11). pii: JCM.00886-19. doi: 10.1128/JCM.00886-19. Print 2019 Nov.
Impact factor: 4.959
Publication type: Paper in international publication
Authors: Fernandez-Huerta, Miguel, Bodiyabadu, Kaveesha, Esperalba, Juliana, Bradshaw, Catriona S, Serra-Pladevall, Judit, Garland, Suzanne M, Fernandez-Naval, Candela, Jensen, Jorgen S, Pumarola, Tomas, Ebeyan, Samantha et al.
DOI: 10.1128/JCM.00886-19

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

PMID: 31434719
Journal: JOURNAL OF CLINICAL MICROBIOLOGY
Year: 2019
Reference: J Clin Microbiol. 2019 Oct 23;57(11). pii: JCM.00886-19. doi: 10.1128/JCM.00886-19. Print 2019 Nov.
Impact factor:
Publication type: Paper in international publication
Authors: Bodiyabadu, Kaveesha; Bradshaw, Catriona S; Ebeyan, Samantha; Espasa, Mateu; Esperalba, Juliana; Fernandez-Huerta, Miguel; Fernandez-Naval, Candela; Garland, Suzanne M; Jensen, Jorgen S; Lundgren, Marie et al.
DOI: 10.1128/JCM.00886-19

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

PMID: 31088831
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14.
Impact factor: 8.911
Publication type: Paper in international publication
Authors: Santiago-Walker, Ademi E, Poggesi, Italo, Parekh, Trilok, Xie, Hong, Infante, Jeffrey R, Tabernero, Josep, Zhong, Bob, Gonzalez, Martha D, Spira, Alexander I, Govindan, Ramaswamy et al.
DOI: 10.1158/1078-0432.CCR-18-3334

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

PMID: 31088831
Journal: CLINICAL CANCER RESEARCH
Year: 2019
Reference: Clin Cancer Res. 2019 Aug 15;25(16):4888-4897. doi: 10.1158/1078-0432.CCR-18-3334. Epub 2019 May 14.
Impact factor:
Publication type: Paper in international publication
Authors: Awad, Mark M; Bahleda, Rastilav; Calvo, Emiliano; Cervantes, Andres; Chan, Nancy; Gonzalez, Martha D; Govindan, Ramaswamy; Hierro, Cinta; Infante, Jeffrey R; Italiano, Antoine et al.
DOI: 10.1158/1078-0432.CCR-18-3334

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

PMID: 31506079
Journal: BMC Pediatrics
Year: 2019
Reference: BMC Pediatr. 2019 Sep 10;19(1):326. doi: 10.1186/s12887-019-1689-y.
Impact factor: 1.983
Publication type: Paper in international publication
Authors: Bartha, J M, Galindo, A, Martinez, J M, Gomez-Roig, L, Crispi, F, Gomez, O, Carreras, E, Cabero, L, Gratacos, E, Llurba, E et al.
DOI: 10.1186/s12887-019-1689-y

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

PMID: 31506079
Journal: BMC Pediatrics
Year: 2019
Reference: BMC Pediatr. 2019 Sep 10;19(1):326. doi: 10.1186/s12887-019-1689-y.
Impact factor:
Publication type: Paper in international publication
Authors: Antolin, E; Arevalo, S; Bartha, J M; Boix, H; Cabero, L; Carreras, E; Comas, M; Crispi, F; Cruz-Lemini, M; Dolader, P et al.
DOI: 10.1186/s12887-019-1689-y

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

PMID: 31008727
Journal: ANTI-CANCER DRUGS
Year: 2019
Reference: Anticancer Drugs. 2019 Jul;30(6):628-635. doi: 10.1097/CAD.0000000000000794.
Impact factor: 1.801
Publication type: Paper in international publication
Authors: Casado, Antonio, Vicente, David, Ortega, Eugenia, Herrero, Ana, Guerra, Eva, Barretina-Ginesta, Pilar, Rubio, Maria J, Martinez, Alejandro, Bover, Isabel, Vidal, Laura et al.
DOI: 10.1097/CAD.0000000000000794

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

PMID: 31008727
Journal: ANTI-CANCER DRUGS
Year: 2019
Reference: Anticancer Drugs. 2019 Jul;30(6):628-635. doi: 10.1097/CAD.0000000000000794.
Impact factor:
Publication type: Paper in international publication
Authors: Arcusa, Angels; Barretina-Ginesta, Pilar; Bover, Isabel; Casado, Antonio; Del Campo, Jose M; Garcia, Yolanda; Gonzalez-Martin, Antonio; Gonzalez-Santiago, Santiago; Guerra, Eva; Herrero, Ana et al.
DOI: 10.1097/CAD.0000000000000794

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

PMID: 30408481
Journal: CLINICA CHIMICA ACTA
Year: 2019
Reference: Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5.
Impact factor: 2.735
Publication type: Paper in international publication
Authors: Oterino, Agustin, Segundo, David San, Cuello, Juan Pablo, Gil-Herrera, Juana, Camara, Carmen, Gomez-Gutierrez, Montserrat, Martinez-Hernandez, Eugenia, Meca-Lallana, Virginia, Moga, Esther, Munoz-Calleja, Cecilia et al.
DOI: 10.1016/j.cca.2018.11.008

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

PMID: 30408481
Journal: CLINICA CHIMICA ACTA
Year: 2019
Reference: Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5.
Impact factor:
Publication type: Paper in international publication
Authors: Alari-Pahissa, Elisenda; Aragon, Larraitz; Camara, Carmen; Castillo-Trivino, Tamara; Cuello, Juan Pablo; Eixarch, Herena; Ferrer, Joana Maria; Gascon-Gimenez, Francisco; Gil-Herrera, Juana; Gomez-Gutierrez, Montserrat et al.
DOI: 10.1016/j.cca.2018.11.008

Publications

Publications searcher

Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013).

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

Mosunetuzumab Induces Complete Remissions in Poor Prognosis Non-Hodgkin Lymphoma Patients, Including Those Who Are Resistant to or Relapsing After Chimeric Antigen Receptor T-Cell (CAR-T) Therapies, and Is Active in Treatment through Multiple Lines.

Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia.

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

"Moving Fourth": A Vision Toward Achieving Healthy Living with HIV Beyond Viral Suppression.

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics.

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

Mucosal RNA and Protein Expression as the next frontier in IBS: abnormal function despite morphologically intact small intestinal Mucosa.

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium.

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Multicenter prospective clinical study to evaluate children short-term neurodevelopmental outcome in congenital heart disease (children NEURO-HEART): study protocol.

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

Patronage:

Collaborating:

Accreditations: